Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-12 08:02 am Purchase |
2021-03-31 | 13G | Theravance Biopharma, Inc. TBPH |
WELLINGTON MANAGEMENT CO LLP | 7,602,745 11.660% |
1,993,118 (+35.53%) |
Filing History |
| 2021-02-12 5:10 pm Purchase |
2020-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
ORBIMED ADVISORS LLC | 5,544,212 8.670% |
5,544,212 (New Position) |
Filing History |
| 2021-02-12 4:26 pm Sale |
2021-02-12 | 13G | Theravance Biopharma, Inc. TBPH |
BAUPOST GROUP LLC | 9,605,996 14.810% |
-574,000 (-5.64%) |
Filing History |
| 2021-02-10 11:57 am Purchase |
2020-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
The Vanguard Group | 4,654,309 7.270% |
650,707 (+16.25%) |
Filing History |
| 2021-02-08 10:33 am Purchase |
2021-02-05 | 13G | Theravance Biopharma, Inc. TBPH |
FMR CORP | 9,607,310 15.000% |
1,083,137 (+12.71%) |
Filing History |
| 2021-02-05 08:03 am Purchase |
2020-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
BLACKROCK INC BLK |
4,491,195 7.000% |
113,268 (+2.59%) |
Filing |
| 2021-02-03 1:22 pm Purchase |
2020-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
WELLINGTON MANAGEMENT CO LLP | 5,609,627 8.770% |
2,432,090 (+76.54%) |
Filing History |
| 2020-07-10 10:48 am Sale |
2020-06-30 | 13G | Theravance Biopharma, Inc. TBPH |
BLACKROCK INC BLK |
4,377,927 6.900% |
-4,304,752 (-49.58%) |
Filing |
| 2020-06-23 4:21 pm Sale |
2020-06-04 | 13G | Theravance Biopharma, Inc. TBPH |
Link Fund Solutions Ltd | 0 0.000% |
-5,251,349 (Position Closed) |
Filing History |
| 2020-06-22 5:13 pm Unchanged |
2020-06-22 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 15.300% |
0 (Unchanged) |
Filing History |
| 2020-06-17 4:07 pm Sale |
2020-06-17 | 13D | Theravance Biopharma, Inc. TBPH |
GLAXOSMITHKLINE PLC | 9,644,807 15.300% |
-1 (-0.00%) |
Filing History |
| 2020-06-11 11:43 am Unchanged |
2020-06-04 | 13G | Theravance Biopharma, Inc. TBPH |
ACACIA RESEARCH CORP ACTG |
0 0.000% |
0 (Unchanged) |
Filing History |